Prostate & Genitourinary Cancer Clinical Trials
The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.
Kidney Clinical Trials
A Phase II Study of VEGF Blockade with Bevacizumab Combined with Autologous Tumor/Dendritic Cell Vaccine (DC vaccine), Interleukin-2 (IL-2) and Interferon-a-2b (IFNa2b) in Patients with Metastatic Renal Cell Carcinoma (RCC)
Kidney
D0708
Ernstoff
A Rollover Protocol to Allow Continued Access to Tivozanib (AV-951) for Subjects Enrolled in Other Tivozanib Protocols
Kidney
F11099
Ernstoff
A Study of the Effect of Sorafenib on p63 Expression and Keratinocyte Differentiation in Human Skin
Kidney
D11004
Danilov
Alternating Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma: A Phase II Study of Alternating Sunitinib and Temsirolimus
Kidney
D1011
Ernstoff
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Kidney
D0946
Bakitas
Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor
Kidney
AREN0532
Chaffee
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
Kidney
AREN0533
Chaffee
Other Male Genital Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Male Genital
D0946
Bakitas
Other Urinary Clinical Trials
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Other Urinary
D0946
Bakitas
Prostate Clinical Trials
18F-Fluoride PET/CT Versus 99mTc-MDP Scanning for Detecting Bone Metastases: A Randomized, Multi-Center Trial to Compare Two Bone Imaging Techniques
Prostate
W0847
Seltzer
A Phase I Dose Escalation Study of Hydroxyurea in Combination with SCH900776 in Advanced Malignant Solid Tumors
Prostate
D1049
McGowan
A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
Prostate
R0815
Hartford
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising Psa After Radical Prostatectomy
Prostate
R0534
Hartford
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Prostate
D0946
Bakitas
RTOG 0924: Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Prostate
R0924
Hartford
Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Prostate
C90203
Seigne
Surgical Margin Assessment During Radical Prostatectomy - a Deformation Study
Prostate
D1003
Halter
Urinary Bladder Clinical Trials
A Phase I/II Trial of A Combination of Paclitaxel and Trastuzumab with Daily Irradiation OR Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer
Urinary Bladder
R0524
Hartford
A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following A Thorough Transurethral Surgical Re-Staging
Urinary Bladder
R0926
Hartford
Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects
Urinary Bladder
D0946
Bakitas
